20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
The World Health Organization said that global distribution of the AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine remains unruffled, though much of Europe has stopped using the shot after reports of blood clots in some people shortly after immunization, reports Washington Post.
- The EMA has not recommended that authorities suspend the use and WHO also came out to advise against halting vaccinations.
- Sweden and Latvia are the latest European countries to pause the vaccinations against COVID-19 using AstraZeneca’s vaccine as a precautionary measure.
- The reassurance from WHO comes as Australia said that it would continue to use the vaccine, which successfully protects against the infection.
- Thailand’s prime minister also became the country’s first person to be vaccinated with the AstraZeneca shot after the country briefly halted its rollout due to blood clot concerns in Europe.
- Bloomberg notes that Africa Centers for Disease Control is reviewing the shot amid the possible safety concerns.
- Price Action: AZN shares are trading 2.58% higher at $50.03 in premarket on the last check Tuesday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!